<DOC>
	<DOC>NCT01254682</DOC>
	<brief_summary>The primary objective of this study is to evaluate the efficacy and safety of Ostenil application (1% hyaluronan) after arthroscopy of the wrist.</brief_summary>
	<brief_title>Intra-articular Hyaluronan Substitution in Arthroscopy of the Wrist</brief_title>
	<detailed_description />
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Male and female patients between 18 and 80 years of age Minimum pain score of 2 according to modified Mayo Wrist Score Patients in good general health/nutritional condition Signed written informed consent Alcohol / drug abuse, drug addiction or neurotic personality disorder; patients with mental illness or suicidal tendency Severe intercurrent illness (like uncontrolled diabetes mellitus or thyroid disease, carcinoma,...) Fertile women without medically secured contraception(hysterectomy, sterilization, contraceptives,...) Subjects having a high probability of non compliance to the study procedures according to investigator's judgement (like illiteracy, insufficient German linguistic knowledge) Contraindication for the use of one of the investigational products or for the scheduled anesthesia Concomitant or previous participation in a clinical trial within the last 3 months Intraarticular treatment with a sodium hyaluronatebased product within the last 6 months Intraarticular treatment by the use of corticoid containing substance within the last 3 months Concomitant illness or injury influencing study evaluation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>wrist</keyword>
	<keyword>joint</keyword>
	<keyword>arthroscopy</keyword>
	<keyword>hyaluronan</keyword>
	<keyword>hyaluronic acid</keyword>
	<keyword>Necessity of Arthroscopic surgery</keyword>
</DOC>